FDA Ortho Panel Will See Second Hip Resurfacing System In Cormet
This article was originally published in The Gray Sheet
Executive Summary
Corin Group's Cormet will be the second hip resurfacing product to go before an FDA advisory committee when the Orthopaedic and Rehabilitation panel considers the device's PMA next month